New immunotherapy attempts to fight childhood brain cancer

This early-stage study tested a new immunotherapy approach for children whose ependymoma (a type of brain tumor) had come back after standard treatment. The therapy combined a peptide vaccine designed to train the immune system to attack tumor cells with a skin cream (imiquimod) that boosts immune response. The main goals were to check safety and see if the vaccine could activate the child's immune system against the tumor.